NEW YORK, Feb. 15, 2026 (GLOBE NEWSWIRE) --
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors ...
NEW YORK, Feb. 15, 2026 (GLOBE NEWSWIRE) --